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The murine cpk mouse develops a rapid-onset polycystic kidney disease (PKD) with many similarities to human PKD.
uring kidney development, the transcription factor Pax2 is required for the specification and differentiation of the renal
pithelium. In humans, Pax2 is also expressed in juvenile cystic kidneys where it correlates with cell proliferation. In this
eport, Pax2 expression is demonstrated in the cystic epithelium of the mouse cpk kidneys. To assess the role of Pax2 during
the development of polycystic kidney disease, the progression of renal cysts was examined in cpk mutants carrying one or
two alleles of Pax2. Reduced Pax2 gene dosage resulted in a significant inhibition of renal cyst growth while maintaining
more normal renal structures. The inhibition of cyst growth was not due to reduced proliferation of the cystic epithelium,
rather to increased cell death in the Pax2 heterozygotes. Increased apoptosis with reduced Pax2 gene dosage was also
observed in normal developing kidneys. Thus, increased cell death is an integral part of the Pax2 heterozygous phenotype
and may be the underlying cause of Pax gene haploinsufficiency. That the cystic epithelium requires Pax2 for continued
expansion underscores the embryonic nature of the renal cystic cells and may provide new insights toward growth
suppression strategies. © 2000 Academic Press



















Polycystic kidney disease (PKD) is among the most com-
mon genetic disorders in the adult population. It has been
proposed that the renal cystic epithelial cell has dedifferen-
tiated to a more embryonic phenotype, leading to increased
cellular proliferation, mislocalization of apical and basolat-
eral cell surface markers, and increased expression of spe-
cific basement membrane components (Calvet, 1993, 1998).
In humans, autosomal dominant PKD (ADPKD) has been
associated with mutations in at least two genes, ADPKD1
(The European PKD Consortium, 1994) and ADPKD2 (Mo-
chizuki et al., 1996), that encode large transmembrane
proteins which are known to associate (Qian et al., 1997). In
ouse, at least five loci that can generate a PKD phenotype
pon disruption have been identified (Schieren et al., 1996).
mong the best characterized mouse PKD mutants is the
ongenital polycystic kidney (cpk) mouse (Gattone et al.,
988, 1996). The cpk mutation is recessive, maps to mouse
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250hromosome 12 (Simon et al., 1994), and was originally
dentified in the C57BL6 strain. Homozygous cpk animals
evelop cysts from birth and die at approximately 3 weeks
rom acute renal failure. At the cellular level, the cpk
utant mouse exhibits many of the same traits found in
uman PKD, including mislocalization of the EGF receptor
Orellana et al., 1995) and altered deposition of basement
embrane proteins (Nagao et al., 1994; Ojeda, 1999; Rocco
t al., 1992; Taub et al., 1990). Mutations in PKD1 or PKD2
ccount for about 95% of the clinical PKD cases, leaving at
east 5% of human PKD unaccounted for. Whether the
ouse cpk gene, which has not yet been identified but does
ot correspond to either human PKD1 or PKD2, is associ-
ted with this minority of human PKD remains to be
etermined.
During embryonic development, the Pax2 gene is essen-
ial for the differentiation and proliferation of the renal
pithelium in both mouse (Keller et al., 1994; Rothenpieler
nd Dressler, 1993; Torres et al., 1995) and man (Sanya-
usin et al., 1995a,b; Schimmenti et al., 1995). Pax2, like
ther members of the Pax gene family, is haploinsufficient
uch that mice and humans heterozygous for loss of func-
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251Pax2 Gene Dosage and Cystic Diseasetion alleles show slightly reduced renal mass, occasional
unilateral renal agenesis, and eye and ear abnormalities.
During the normal course of kidney development, Pax2 is
expressed in the nephric duct, the ureteric bud, and the
induced renal mesenchyme which ultimately generates
much of the glomerular, proximal tubular, and distal tubu-
lar epithelium (Dressler and Douglass, 1992). In the mouse,
expression persists from embryonic day 11 until approxi-
mately 10 days after birth, particularly in the nephrogenic
zone where new nephrons continue to from and epithelial
cells are proliferating. Pax2 expression is down-regulated in
the glomerulus and in proximal and distal tubules as the
epithelial cells mature (Dressler and Douglass, 1992; Ryan
et al., 1995). Strikingly, juvenile cystic and dysplastic
kidneys show persistent Pax2 expression that correlates
with cell division and bcl2 expression (Winyard et al.,
1996b). Deregulated expression of Pax2 in transgenic mice
results in glomerular and proximal tubule microcyst forma-
tion and renal failure(Dressler et al., 1993). Persistent
expression of Pax2 has also been described in other prolif-
erative abnormalities in the kidney, including Wilms’ tu-
mor (Dressler and Douglass, 1992) and renal cell carcinoma
(Gnarra and Dressler, 1995).
To directly address whether Pax2 regulates the initiation
and progression of renal cystic disease or is merely a marker
for proliferating, undifferentiated epithelial cells, we exam-
ined the effects of Pax2 haploinsufficiency in mice with the
cpk mutation. Within the cpk homozygous population,
Pax2 heterozygous animals exhibit more slowly progressing
cystic disease, indicating an inhibitory effect of reduced
gene dosage. The inhibition of cyst growth was not due to
reduced cell proliferation, rather to increased apoptosis in
Pax2 heterozygotes. Furthermore, increased cell death is
the underlying cause of Pax2 haploinsufficiency in normal
kidneys as well. Thus, Pax2 expression and gene dosage in
cystic epithelium can modify the progression of renal cystic
disease in mice. The data support the hypothesis that the
renal cystic epithelium remains in a non-terminally differ-
entiated state and is regulated, at least in part, by develop-
mental transcription factors.
MATERIALS AND METHODS
Animals. Male mice carrying the cpk mutation in a C57BL6
background were a generous gift from V. Gattone, University of
Kansas Medical School. An F1 hybrid strain was generated by
mating to C3H females. These F1 female offspring were tested for
the cpk mutation by backcrossing to the founder cpk/1 males and
hecking for cystic offspring. Positive cpk F1 animals must carry
he mutant C57BL6 allele at the cpk locus. The Pax2 null muta-
ion, originally generated in the 129 strain, was bred into the C3H
train by repeated crossing over six generations. C3H Pax2 1/2
ice were mated to the cpk2/1 F1 mice to generate double
eterozygotes carrying the C57BL6 cpk allele and one copy of the
ax2 gene. The cpk2/1; Pax22/1 double heterozygotes were
rossed to cpk/1 animals to generate cpk homozygous pups that
arried either one or two copies of the Pax2 gene.
p
t
Copyright © 2000 by Academic Press. All rightGenotyping. Genomic DNA was extracted from tail biopsies
y overnight digestion with protease K in 100 mM NaCl, 10 mM
ris, pH 8, 1% SDS. Samples were treated with RNase, extracted
ith phenol:chloroform, and ethanol precipitated. The microsatel-
ite markers D12Mit10, D12Mit12, and D12Mit58 were used to
istinguish the C57BL6 and C3H alleles around the cpk gene. PCR
roducts were separated on 4% metaphor agarose gels (FMC). Pax2
enotyping was done by Southern blot analysis of EcoRI-digested
ail DNA. A 1.3-kb NotI–KpnI fragment, extending from upstream
enomic sequences into the first exon, was used to distinguish the
ormal from the mutant allele.
Tissue analysis. Kidneys were removed and either frozen di-
ectly in liquid nitrogen or fixed in 4% paraformaldehyde for
istology and immunostaining. For immunostaining kidneys were
xed for 2 h, washed in PBS, and incubated overnight in 0.5 M
ucrose, PBS before being frozen in liquid nitrogen. For histology,
idneys were fixed overnight in paraformaldehyde, dehydrated, and
mbedded in paraffin. Serial sections were stained with hematoxy-
in and eosin. Four independently derived cystic kidneys were
ectioned for both Pax21/1 and Pax21/2 genotypes at 3 days and
t 10 days after birth for a total of 16 samples.
Immunostaining. Cryostat sections were cut at 8 mm, collected
on gelatinized slides, and air dried for 30–60 min. Immunostaining
was as described by Harlow and Lane (1988). Sections were fixed in
acetone for 5 min in 3% paraformaldehyde, washed in PBS, and
permeabilized in 0.05% Triton X-100 in PBS. A 10 mg/ml dilution
of anti-Pax2 IgG or control, prebleed IgG was prepared in 2% goat
serum in PBS, and 20 ml was applied to each section. Slides were
ncubated at room temperature in a humid chamber and then
ashed twice in PBS, 0.05% Tween. The second antibodies were
iluted 1:300 for the TRITC- or FITC-conjugated anti-rabbit
Sigma) in 2% goat serum in PBS. After a 30-min incubation, slides
ere washed twice in PBS/Tween and covered with Gelvatol.
hotomicrographs were taken with a Nikon ES800 fluorescence
icroscope. The E-cadherin antibody was from Sigma (U-3254); the
ax2 (Dressler and Douglass, 1992) and cadherin-6 (Cho et al.,
998) antibodies have been described.
Cell proliferation and apoptosis. P3 and P21 mice were in-
ected with BrdU (Sigma) in PBS at a concentration of 3 mg/100 g
ody mass. Mice were sacrificed after 2 or 4 h. Kidneys were
emoved, immersed in OCT, and flash frozen. Sections were cut at
mm and permeabilized with 2 N HCl, 0.5% Triton X-100, PBS for
min. Anti-BrdU (Sigma) was diluted 1:100 in PBS, 0.5% Tween 20,
2% goat serum. After incubation for 30 min with TRITC-
conjugated anti-mouse antibodies (Sigma) the sections were coun-
terstained with 1 mg/ml DAPI. Sections were rinsed three times
nd mounted with Gelvatol. Micrographs were taken with a Nikon
S800 using broad band filters. The total number of cells and the
umber of BrdU-positive cells were counted over a given area. Four
ndependently derived litters were injected and sections were
nalyzed from at least four kidneys for each genotype.
The TUNEL reaction was performed using the Apoptag kit
Boehringer Mannheim, Inc.) according to the manufacturer’s pro-
ocol. The permeabilization time was increased to 20 min and the
ections were counterstained with 2.5 ng/ml propidium iodide.
ore each genotype, four different kidneys were sectioned. The
ections were photographed under fluorescence illumination with
403 lens. At least 10 data points were taken for each kidney, for
hich the number of positive apoptotic bodies and the total
umber of nuclei were counted within a micrograph and the
yknotic index was expressed as the ratio of apoptotic bodies to the
otal number of nuclei.




























252 Ostrom et al.RESULTS
We hypothesized that Pax2 expression might be present
n the cystic epithelium of cpk kidneys, given the results
btained with human juvenile cystic kidneys (Winyard et
l., 1996b). In the cpk mutant, cysts are thought to originate
rimarily from distal tubules and collecting ducts. This was
onfirmed with anti-cadherin antibodies at 3 and 10 days
ostpartum (P3 and P10), indicating that most cysts derived
rom the E-cadherin-expressing distal tubule and collecting
uct epithelium (Fig. 1A) and not from the developing
roximal tubules which express cadherin-6 (Fig. 1B). Immu-
ostaining revealed distinct Pax2 nuclear expression in
any cystic epithelial cells at P10, but little staining in the
oncystic epithelium or interstitial cells (Figs. 1C and 1D).
nly at later times were cysts positive for cadherin-6,
FIG. 1. Immunostaining of cystic epithelium. (A) Anti-E-cadheri
(arrows). (B) Same section as A stained with anti-cadherin-6. Not
(arrowheads) but not in the cystic epithelium (arrows). (C) Expres
epithelium (arrows) but not in noncystic tissue (arrowheads). (D) H
of 10-day cpk kidney. Note that large cysts have lost much of the E
B, C, and E and 25 mm for D.howing that cyst growth had extended into the proximal
ubule (data not shown). Strikingly, large cysts had less
Copyright © 2000 by Academic Press. All right-cadherin expression at the basolateral side (Fig. 1E),
hich may indicate a loss of epithelial cell polarity and
ight junctions.
To determine whether the persistent expression of Pax2
n the cystic epithelium was a contributing factor to cyst
rowth, the effect of Pax2 gene dosage was examined by
crossing the Pax2 null allele (Torres et al., 1995) into cpk
heterozygotes. An F1 founder generation was bred by cross-
ing cpk heterozygous C57BL6 males to either wild-type
3H females or Pax2 heterozygous females within a C3H
enetic background. Double-heterozygous male F1 founders
hat carried the cpk allele, derived from the C57BL6 strain,
nd the Pax2 null allele were identified. These males were
rossed to female F1 mice (C57BL6/C3H) which carried
nly the cpk allele to generate the F2 animals for analysis.
As both parental mice were hybrid strains of 50% C3H and
ining of 3-day cpk kidney. Note expression in cystic epithelium
ression in comma- and S-shaped bodies of the nephrogenic zone
of Pax2 in cpk kidney at 10 days. Note nuclear staining in cystic
r magnification of 10-day cpk kidney. (E) Anti-E-cadherin staining
herin staining at the basolateral sides. Bars represent 50 mm for A,n sta
e exp
sion
ighe50% C57BL6, the overall genetic complement of the F2
generation will still be 50:50 although individual loci can be





253Pax2 Gene Dosage and Cystic Diseasehomozygous for either the C3H or the C57BL6 allele. The
F2 pups were sacrificed 3 and 10 days postnatally and
genotyped for the cpk allele using strain-specific polymor-
phisms of microsatellite markers near the cpk locus. At
oth 3 and 10 days, cyst were already evident and correlated
ith the presence of the C57BL6 allele near the cpk locus.
Within a single litter, homozygous cpk offspring could have
either one or two copies of the Pax2 gene. Multiple litters
were examined from five mating pairs over a period of 6
months.
Kidneys from P3 and P10 pups were dissected out,
weighed, and prepared for immunostaining and histology.
Total wet weight was used as an indication of size (Fig. 2).
At P3, noncystic kidneys containing only one copy of the
Pax2 gene tended to be slightly smaller than their wild-type
counterparts, 17.7 6 3.5 mg versus 20.4 6 5.9 mg, although
this difference was not statistically significant (P , 0.2).
This size difference was significant at P10, with Pax21/2
kidneys weighing 36.9 6 7.7 mg and Pax21/1 kidneys
weighing 47.7 6 7.5 mg (P , 0.01). Among the cystic
kidneys, there was a clear effect of Pax2 gene dosage even at
3 days (Fig. 2). Homozygous cpk kidneys with two copies of
Pax21/1 were more than twice the weight of homozygous
cpk kidneys with only one copy of Pax2 (P , 0.01). In fact,
FIG. 2. Comparative wet weights of kidneys from normal and
cystic mice carrying either one or two copies of the Pax2 gene.
Kidneys were taken at 3 or 10 days as indicated. Weights are
averages plus 1 standard deviation from the mean. Genotypes are
listed below, the number of samples (n) is given for 3 and 10 days
respectively: 1—Pax21/1:cpk1/1 (n 5 13, 17), 2—Pax21/2:
pk1/1 (n 5 15, 12), 3—Pax21/1:cpk2/2 (n 5 7, 17), 4—Pax21/
:cpk2/2 (n 5 10, 9).Pax21/2 cystic kidneys were not significantly larger than
noncystic kidneys, even though histological analysis ulti-
Copyright © 2000 by Academic Press. All rightmately revealed small cysts present. By P10, Pax2 gene
dosage had a remarkable effect on slowing of cyst growth.
Cystic kidneys wild type for Pax2 were threefold larger than
cpk homozygote kidneys with only one copy of Pax2 (P ,
0.001).
Histology revealed that Pax2 heterozygotes had smaller
cysts at both P3 and P10, compared to Pax21/1:cpk2/2
mice, and generally had more normal glomeruli and tubules
remaining (Fig. 3). By P3, cpk2/2:Pax21/1 mice had large
cysts extending through the cortex and to the nephrogenic
zone (Fig. 3A), with many smaller cysts in the medullary
zone and cortex. In contrast, cpk2/2:Pax21/2 mice had
small cysts primarily in the medullary zone (Fig. 3B). By
P10, kidneys from cpk2/2:Pax21/1 mice within this hy-
brid background were almost completely cystic, with large
fluid-filled cysts having displaced almost all of the
nephrons and extending completely to the renal capsule
(Fig. 3C). In contrast, cpk2/2:Pax21/2 mice had signifi-
cantly more normal renal tubules in the cortex, particularly
within the periphery where the youngest nephrons are
located (Fig. 3D). Since the origin of the cysts is primarily
collecting duct and distal tubule (Avner et al., 1987), cysts
are first apparent in the medullary zone and progress into
the cortex. This progression appears delayed in the
Pax21/2 mice, as cortical cysts are rarely detected at 3
days. By 10 days, cpk2/2:Pax21/2 kidneys exhibit large
cysts in the medullary zone that have not extended to the
peripheral zone of the cortex, unlike the Pax21/1:cpk2/2
mice. Within this hybrid genetic background, homozygous
cpk mice with two copies of Pax2 always died within 3
weeks, whereas Pax21/2:cpk2/2 mice generally survived
longer with many individuals lasting 4–6 weeks.
Taken together, the data demonstrate an inhibition of
cyst growth in the Pax2 heterozygous cpk animals. Such
inhibition could be due to reduced rates of cellular prolif-
eration or increased cell death. In order to distinguish
between these two possibilities, cell proliferation was as-
sayed by in vivo BrdU labeling and the number of cells
undergoing apoptosis was scored by the TUNEL assay. Mice
were sacrificed 2 and 4 h after BrdU injection and the
kidneys sectioned for immunostaining with anti-BrdU an-
tibodies. Cellular proliferation index was expressed as the
ratio of BrdU-positive nuclei relative to the total number of
nuclei per given area. Apoptosis was assayed using the
TUNEL reaction and the pyknotic index was expressed as
the ratio of labeled to unlabeled nuclei per given area.
Representative pictures are shown in Fig. 4 and the data in
Table 1. Cellular proliferation at 3 days is extensive and
encompasses the nephrogenic zone, where epithelial cells
are still differentiating; the cortex; and the medullary zone,
where ascending and descending limbs of Henle’s loop are
forming in new nephrons. There was no significant differ-
ence in cellular proliferation among the genotypes tested
(Table 1, Figs. 4E and 4F). Pax2 gene dosage did not affect
proliferation in either the wild-type or the cpk background.
However, Pax2 gene dosage had a very significant effect on
cell death in both wild-type and cpk mice. Heterozygous
















254 Ostrom et al.Pax21/2 animals exhibited a twofold increase in the pyk-
notic index, relative to the Pax21/1 genotypes (Table 1). At
days, increased apoptosis was clearly evident in the
ephrogenic zone of Pax21/2 mice (Figs. 4A and 4B),
egardless of the cpk genotype. At 3 days, apoptosis in cystic
pithelium was difficult to detect, primarily because the
ercentage of apoptotic bodies is low, probably due to rapid
learance, and cystic cells reflected a small percentage of
he total. However, at 21 days, Pax21/2 mice again exhib-
ted a twofold increase in apoptotic bodies in cystic epithe-
ium (Figs. 4C and 4D; Table 1).
DISCUSSION
In the mouse cpk model, Pax2 gene dosage can affect the
progression of cystic kidney disease, which is characterized
by continued proliferation and dedifferentiation of the renal
epithelium. The results further underscore the embryonic
nature of the cystic epithelium and point to an essential
FIG. 3. Renal histology of cystic kidneys. (A) 3-day-old kidney f
cpk2/2 mouse. Note that smaller cysts are located more in th
Pax21/1:cpk2/2 kidney. (D) 10-day-old Pax21/2:cpk2/2 kidne
compared to C. The bar in A represents 100 mm. Representative srole for Pax2 in protection from apoptosis. Persistent ex-
pression of Pax2 has been observed in human ADPKD1 (Eng
Copyright © 2000 by Academic Press. All rightet al., 1994) and in juvenile cystic kidneys (Winyard et al.,
1996b) and thus does not seem to be a feature unique to the
cpk mouse. Expression of Pax2 is also found in human
ilms tumor (Dressler and Douglass, 1992; Eccles et al.,
992) and renal cell carcinoma and is necessary for the
roliferation of cultured renal tumor cells (Gnarra and
ressler, 1995). Pax2 and its close relatives Pax5 and Pax8
are known to suppress p53 transcription in transfected NIH
3T3 cells by binding to cis-acting regulatory sequences
(Stuart et al., 1995). Misregulation of Pax2 in juvenile cystic
disease also correlates with bcl2 expression (Winyard et al.,
1996a,b). Thus, apoptosis in Pax2 heterozygous kidneys
may be mediated in part by increased levels of p53, which
can promote apoptosis, and decreased levels of bcl2, a gene
that protects cells from death (Hockenbery et al., 1990;
Sorenson et al., 1995).
In this report, we demonstrate that increased cell death is
a hallmark of reduced Pax2 gene dosage and as such can
affect the rate of development and organ size. Within the
nephrogenic zone, Coles et al. (1993) estimated the pyk-
Pax21/1:cpk2/2 mouse. (B) 3-day-old kidney from a Pax21/2:
edullary zone and rarely extend into the cortex. (C) 10-day-old
ote the peripheral tubules are still relatively free of large cysts
ns are shown.rom
e mnotic index of a normal 3-day-old rat kidney to be approxi-
mately 0.7%, in good agreement with our results (0.6%). To



















255Pax2 Gene Dosage and Cystic Diseasecalculate the actual percentage of cells fated to undergo
apoptosis, the clearance rate of apoptotic bodies was esti-
mated to be about 1.5 h in the newborn kidney, suggesting
that as many as 25% of the differentiating epithelial cells
may ultimately die (Coles et al., 1993). The effect of
educed Pax2 gene dosage would double this number and
ignificantly affect the amount of tubular epithelium
resent at similar times. For noncystic kidneys we see a
eduction in renal mass of approximately 25% at 10 days.
ince Pax2 gene dosage would not be expected to affect
FIG. 4. Cell death and proliferation. Genotypes are Pax21/1:cp
UNEL staining in the nephrogenic zone of 3-day kidneys. (C and
nti-BrdU staining of nephrogenic zone at 3 days. The bars represonepithelial cells of the kidney, including interstitial
esenchyme, endothelial, and smooth muscle cells, the
s
P
Copyright © 2000 by Academic Press. All righteduction in mass is consistent with the twofold increase in
he pyknotic index of Pax21/2 mice.
It is difficult to determine precisely which cell types are
ndergoing apoptosis within the nephrogenic zone, because
t the time of chromatin condensation and DNA fragmen-
ation the cells have lost expression of their characteristic
arker proteins. However, many apoptotic bodies are found
ithin the lumen of the developing tubules, suggesting
hey were of epithelial origin. Within the cystic epithelium,
poptotic bodies are also evident. Except for their reduced
in A, C, and E and Pax21/2:cpk2/2 in B, D, and F. (A and B)
UNEL staining in cystic epithelium of 21-day kidneys. (E and F)
0 mm.k2/2ize, which becomes more apparent as the animals mature,
ax2 heterozygous kidneys are relatively normal in both
s of reproduction in any form reserved.
256 Ostrom et al.structure and function. There is no evidence to suggest that
a specific cell type is more prone to apoptosis within the
heterozygous population. Given the constant rate of cell
proliferation, we attribute the reduced kidney size and the
reduction in cyst growth to an increase in programmed cell
death due to reduced Pax2 gene dosage.
Haploinsufficiency has been observed for Pax1, 2, 3, and
6 in both mice and humans, yet the underlying cellular
effects of reduced gene dosage have not been described. In
heterozygous Pax6 mutants, the retina, lens, and pigmented
epithelium of the developing eye are all reduced in size and
cell number (Hanson and van Heyningen, 1995; Theiler et
al., 1978). In Pax1 heterozygous mutants, segmentation of
the vertebral column is affected due to reduced number of
sclerotome-derived intervertebral disc and vertebral body
precursors (Dietrich and Gruss, 1995). Pax1 mutants also
produce fewer thymocytes due to a reduction of the micro-
environment necessary for thymocyte differentiation, the
thymic epithelium and cortical stromal cells where Pax1 is
expressed (Wallin et al., 1996). Although cell proliferation
has not been examined in these mutants, all of the effects
observed in Pax6 and Pax1 heterozygote animals are con-
sistent with increased cell death, as we have observed in the
kidney of Pax2 heterozygotes.
Although genetic background can affect the rate of cys-
togenesis among certain inbred strains of mice (Iakoubova
et al., 1995, 1997; Upadhya et al., 1999), we saw no evidence
of a single gene enhancer or suppresser of cystogenesis
between the C3H and the C57BL6 strains used for this
study. Such an effect would generate a biphasic distribution
of kidney size for a given genotype. Although the distribu-
tion of renal size among cystic animals, of either Pax2
genotype, showed a single peak, we cannot rule out poten-
tial modifier genes between the C3H and the C57BL6
strains that may expand the range of cystic kidney sizes.
However, unless closely linked to the Pax2 locus, such
modifiers would be equally distributed among cpk2/2:
Pax21/1 and cpk2/2:Pax21/2 genotypes and not affect
our overall conclusions. The significant reduction of mean




(days) Region analyzedcpk Pax2
1/1 1/1 3 Nephrogenic zone 21
1/1 1/2 3 Nephrogenic zone 18
2/2 1/1 3 Nephrogenic zone 16
2/2 1/2 3 Nephrogenic zone 21
2/2 1/1 3 Cystic epithelium 21
2/2 1/2 3 Cystic epithelium 16
2/2 1/1 21 Cystic epithelium
2/2 1/2 21 Cystic epitheliumsize, and the increase in apoptosis all point to a critical role
for Pax2 in the progression of renal cysts.
Copyright © 2000 by Academic Press. All rightThe results presented in this report support the hypoth-
esis that PKD consists of dedifferentiated epithelial cells
that require embryonic factors, such as Pax2, for continued
growth and expansion. It remains to be determined just why
the embryonic and cystic epithelial cells are prone to
undergo apoptosis upon reduction of Pax2, a gene normally
down-regulated upon terminal differentiation. It may be
that once cells of the renal epithelial lineage exit the
mitotic cycle, they no longer require high levels of Pax2
expression to protect them from apoptosis. In any event,
reducing the expression levels of such embryonic regulatory
genes may thus be one potential avenue for therapeutic
interventions that aim to slow cyst growth.
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